Panalgo Case Study: Pharma Company Leverages DSM for Observational Study
This landing page describes a pharmaceutical company using Panalgo's Data Science Module (DSM) capabilities, on the Instant Health Data (IHD) platform, to support an observational study. It states the IHD platform "eliminates complex programming, making data analysis faster and decision-making more impactful," but the specific clinical challenge, methodology, and numerical results (e.g., a claimed 6-week timeline) are not present in the fetched page content — it functions as an index/teaser page rather than the full case study.
The customer is anonymised in Norstella’s own case study — not withheld by us.
Norstella is a holding company merging several pharma-intelligence brands — Citeline (trial intelligence), Evaluate (forecasting), MMIT (payer/formulary data) and Panalgo (real-world analytics) — into one data asset.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Norstella on its own site — read the original case study on panalgo.com ↗
Note: Fetched page is a thin index/landing page; no problem statement or numbers are present in the visible content.
Related use cases
- 01Empowering Early Disease Diagnosis with Real-World Data
- 02Refining Rare Disease Targeting with Real-World Data
- 03Gain Real-Time Insights on High-Risk Patient Populations with Real-World Data
- 04Powering Unbiased Outcomes Research with Longitudinal Data
- 05NorstellaLinQ: Better Together: Getting the Full Patient Picture
- 06Trial Rescue & Reconnaissance